glp-1 receptor agonists cardiovascular benefits and drawbacks of agonist use. Abbreviations: GLP-1 Receptor Agonists: The Game-Changer
Description
Ognard J, El Hajj G, Ghozy S et al (2025) Quality of life in patients with spontaneous intracranial hypotension: A systematic review and meta-analysis
Nonetheless, the mechanism underlying the effects of GLP-1RAs in the cardiovascular system remain unclear
References UCL
Although GLP-1RAs can play a favorable role in improving heart failure based on pre-clinical studies, whereas some clinical evidence relevantly have reported that GLP-1RAs treatment could be associated with adverse heart failure events, eg
A variety of GLP-1RAs agents are currently available, including exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and the dual GLP-1/GIP receptor agonist, tirzepatide
